rs17612

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001735.3(C5):​c.4311A>C​(p.Glu1437Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.061 in 1,610,638 control chromosomes in the GnomAD database, including 3,483 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 230 hom., cov: 32)
Exomes 𝑓: 0.063 ( 3253 hom. )

Consequence

C5
NM_001735.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.209

Publications

26 publications found
Variant links:
Genes affected
C5 (HGNC:1331): (complement C5) This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
C5 Gene-Disease associations (from GenCC):
  • complement component 5 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017857254).
BP6
Variant 9-120963648-T-G is Benign according to our data. Variant chr9-120963648-T-G is described in ClinVar as Benign. ClinVar VariationId is 402451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0672 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C5NM_001735.3 linkc.4311A>C p.Glu1437Asp missense_variant Exon 34 of 41 ENST00000223642.3 NP_001726.2 P01031
C5NM_001317163.2 linkc.4329A>C p.Glu1443Asp missense_variant Exon 34 of 41 NP_001304092.1 P01031A0A8Q3SID6Q59GS8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C5ENST00000223642.3 linkc.4311A>C p.Glu1437Asp missense_variant Exon 34 of 41 1 NM_001735.3 ENSP00000223642.1 P01031

Frequencies

GnomAD3 genomes
AF:
0.0454
AC:
6910
AN:
152210
Hom.:
230
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0188
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0547
Gnomad ASJ
AF:
0.0629
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0741
Gnomad FIN
AF:
0.0132
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0649
Gnomad OTH
AF:
0.0478
GnomAD2 exomes
AF:
0.0537
AC:
13490
AN:
251280
AF XY:
0.0547
show subpopulations
Gnomad AFR exome
AF:
0.0191
Gnomad AMR exome
AF:
0.0578
Gnomad ASJ exome
AF:
0.0646
Gnomad EAS exome
AF:
0.000870
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.0685
Gnomad OTH exome
AF:
0.0570
GnomAD4 exome
AF:
0.0626
AC:
91337
AN:
1458310
Hom.:
3253
Cov.:
30
AF XY:
0.0630
AC XY:
45745
AN XY:
725660
show subpopulations
African (AFR)
AF:
0.0181
AC:
605
AN:
33420
American (AMR)
AF:
0.0566
AC:
2532
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0618
AC:
1613
AN:
26108
East Asian (EAS)
AF:
0.000731
AC:
29
AN:
39674
South Asian (SAS)
AF:
0.0673
AC:
5796
AN:
86146
European-Finnish (FIN)
AF:
0.0168
AC:
896
AN:
53400
Middle Eastern (MID)
AF:
0.0613
AC:
353
AN:
5760
European-Non Finnish (NFE)
AF:
0.0685
AC:
75917
AN:
1108818
Other (OTH)
AF:
0.0597
AC:
3596
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
3738
7476
11213
14951
18689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2820
5640
8460
11280
14100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0453
AC:
6906
AN:
152328
Hom.:
230
Cov.:
32
AF XY:
0.0430
AC XY:
3202
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0189
AC:
784
AN:
41568
American (AMR)
AF:
0.0545
AC:
834
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0629
AC:
218
AN:
3468
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5192
South Asian (SAS)
AF:
0.0735
AC:
355
AN:
4830
European-Finnish (FIN)
AF:
0.0132
AC:
140
AN:
10616
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0649
AC:
4414
AN:
68034
Other (OTH)
AF:
0.0473
AC:
100
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
337
675
1012
1350
1687
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0615
Hom.:
932
Bravo
AF:
0.0472
TwinsUK
AF:
0.0739
AC:
274
ALSPAC
AF:
0.0667
AC:
257
ESP6500AA
AF:
0.0229
AC:
101
ESP6500EA
AF:
0.0698
AC:
600
ExAC
AF:
0.0549
AC:
6662
Asia WGS
AF:
0.0340
AC:
118
AN:
3478
EpiCase
AF:
0.0701
EpiControl
AF:
0.0711

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
5.4
DANN
Benign
0.96
DEOGEN2
Benign
0.079
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
PhyloP100
-0.21
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.073
Sift
Benign
0.14
T
Sift4G
Benign
0.43
T
Polyphen
0.0020
B
Vest4
0.062
MutPred
0.26
Loss of ubiquitination at K1440 (P = 0.1741);
MPC
0.16
ClinPred
0.0035
T
GERP RS
-2.9
Varity_R
0.38
gMVP
0.53
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17612; hg19: chr9-123725926; COSMIC: COSV56327119; COSMIC: COSV56327119; API